1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B1899
    Taurodeoxycholic acid Inhibitor ≥98.0%
    Taurodeoxycholate sodium salt 是一种胆盐相关的阴离子洗涤剂。Taurodeoxycholic acid 是在肝脏中将脱氧胆酸与 Taurine (HY-B0351) 偶联形成的。Taurodeoxycholic acid 可用于分离膜蛋白,包括线粒体内膜蛋白。Taurodeoxycholic acid (TDCA) 具有抗炎和神经保护作用。
    Taurodeoxycholic acid
  • HY-100594
    EUK-134 Inhibitor 98.27%
    EUK-134 是一种合成的超氧化物歧化酶和过氧化氢酶模拟物,可保护大鼠肾脏免受缺血再灌注引起的损伤。EUK-134 是一种具有过氧化氢酶活性的超氧化物歧化酶 (SOD) 模拟物 (SODm)。EUK-134 是一种保护有丝分裂的抗氧化剂。EUK-134 作用于 H9C2 细胞,降低 NF-κB 表达、MDA 水平和蛋白质羰基化。
    EUK-134
  • HY-14806B
    Teneligliptin hydrobromide hydrate

    氢溴酸替格列汀水合物

    Inhibitor 99.97%
    Teneligliptin (MP-513) hydrobromide hydrate 是一种口服活性的和选择性的二肽基肽酶 4 (DPP-4) 抑制剂 (对人和大鼠酶的 IC50s 分别为 0.37 和 0.29 nM)。Teneligliptin hydrobromide hydrate 可改善血糖水平,可用于 2 型糖尿病相关的研究。
    Teneligliptin hydrobromide hydrate
  • HY-N0034
    Arctiin

    牛蒡子苷

    Inhibitor 99.52%
    Arctiin 是一种有口服活性的 NF-κB 抑制剂。Arctiin 抑制人肿瘤细胞的 cyclin D1 蛋白的表达。Arctiin 还能降低丙二醛和促炎细胞因子水平。Arctiin 可用于肾小球肾炎的研究。
    Arctiin
  • HY-119970
    Helenalin Inhibitor 99.92%
    Helenalin 是一种抗炎的倍半萜内酯。Helenalin 通过直接靶向 p65 选择性抑制转录因子 NF-κB。Helenalin 具有烷基化活性,以 NF-κB 的 p65 亚基中的半胱氨酸巯基为靶点,从而抑制其 DNA 结合。
    Helenalin
  • HY-N6673
    Okanin

    奥卡宁

    Inhibitor 99.98%
    Okanin 是 Coreopsis tinctoria 的有效成分。Okanin 通过抑制 TLR4/NF-κB 信号通路减弱 LPS 诱导的小胶质细胞活化。
    Okanin
  • HY-B1971
    Deltamethrin

    溴氰菊酯

    99.93%
    Deltamethrin (Decamethrin) 是一种具有口服活性的人工合成的拟除虫菊酯类杀虫剂。Deltamethrin通过抑制 Nrf2/HO-1 通路诱导氧化应激,导致炎症反应和细胞凋亡 (apoptosis),通过诱导细胞凋亡 (apoptosis) 而发挥抗肿瘤作用,可广泛用于害虫防治。
    Deltamethrin
  • HY-N0272
    Eleutheroside E

    刺五加苷E

    Inhibitor 99.58%
    Eleutheroside E 是一种可口服的刺五加的重要成分。Eleutheroside E 能够抗炎,抗氧化,减轻缺氧-再氧化 (H/R) 损伤引起的心肌细胞凋亡。Eleutheroside E 能够改善 2 型糖尿病,改善认知障碍,具有神经保护作用。
    Eleutheroside E
  • HY-14621
    Zingerone

    姜酮

    Inhibitor 99.79%
    Zingerone (Vanillylacetone) 是一种无毒的甲氧基苯酚,从生姜中得到,具有抗炎、抗糖尿病、抗脂质过敏、抗腹泻、抗痉挛和抗肿瘤等活性。Zingerone 能够缓解氧化应激和炎症,下调 NF-κB 介导的信号通路。Zingerone 作为抗有丝分裂剂,能够抑制神经母细胞瘤的生长。
    Zingerone
  • HY-124284
    Hexamethylene bisacetamide Inhibitor 99.56%
    Hexamethylene bisacetamide (HMBA) 是一种能通过血脑屏障的分化诱导剂和选择性溴域抑制剂。Hexamethylene bisacetamide 可诱导肿瘤细胞分化和抑制细胞增殖,具有抗肿瘤的活性。Hexamethylene bisacetamide 可通过 Notch1Bcl-2p53 信号通路诱导细胞凋亡 (apoptosis)。 此外,Hexamethylene bisacetamide 可改善小鼠的肥胖表型。
    Hexamethylene bisacetamide
  • HY-D0205A
    Carbocisteine

    羧甲司坦

    Inhibitor ≥98.0%
    Carbocisteine 是一种具有口服活性的粘液溶解剂。Carbocisteine 可减轻 NF-κB p65ERK1/2 的磷酸化。Carbocisteine 调节 Nrf2/HO-1NFκB 相互作用。Carbocisteine 抑制凋亡(Apoptosis)。Carbocisteine 可用于慢性阻塞性肺疾病 (COPD) 的研究。
    Carbocisteine
  • HY-115385
    Lumichrome

    光色素

    Inhibitor 99.72%
    Lumichrome 是核黄素的光降解产物,是人体内的一种内源性化合物。Lumichrome 通过 p53 依赖机制抑制人肺癌细胞生长并诱导凋亡 (apoptosis)。Lumichrom 是 AKT/β-catenin 信号通路的抑制剂。
    Lumichrome
  • HY-107574
    TC-E 5003 Modulator 98.03%
    TC-E 5003 是一种选择性蛋白精氨酸甲基转移酶 1 (PRMT1) 抑制剂,对 hPRMT1 的 IC50 值为 1.5 µM。TC-E 5003 调节脂多糖 (LPS) (HY-D1056) 诱导的 AP-1NF-κB 信号通路,具有抗炎特性。TC-E 5003 还上调 Ucp1 和 Fgf21 的表达,激活来自小鼠和人类的原代皮下脂肪细胞中的蛋白激酶 A 信号和脂解作用。TC-E 5003 有望用于肥胖及相关代谢障碍、氧化压力、炎症和癌症的研究。
    TC-E 5003
  • HY-122942
    Moracin M

    桑辛素M

    Inhibitor 98.90%
    Moracin M 是一种酚类成分,能都从桑皮中分离出来,有效的磷酸二酯酶 4 (PDE4) 抑制剂,对于 PDE4D2,PDE4B2,PDE5A1 和 PDE9A2 的 IC50 分别为 2.9 μM,4.5 μM,> 40 μM 和 > 100 μM。Moracin M 具有抗炎活性。
    Moracin M
  • HY-N0847
    Micheliolide

    木香内酯

    Inhibitor 99.77%
    Micheliolide 是一种具有抗癌和抗炎作用的倍半萜内酯,来源于 Michelia compressaMichelia champaca。Micheliolide 可以减少高糖刺激下的小鼠肾小管细胞中 NF-κB 的激活、IκBα 的降解,以及 MCP-1、TGF-β1 和 FN 的表达。Micheliolide 抑制 LPS (HY-D1056) 引起的 NF-κBPI3K/Akt/p70S6K 通路的激活,从而发挥抗炎作用。Micheliolide 抑制黄原酸钠 (DSS) (HY-116282) 引起的炎症性肠病、结肠炎相关癌症和类风湿关节炎。
    Micheliolide
  • HY-134240
    L-Threonic acid magnesium

    L-苏糖酸镁

    Inhibitor ≥99.0%
    L-Threonic acid magnesium (Magnesium L-threonate) 是 Threonic acid 的 L 型对映体和 Vitamin C (HY-B0166) 的代谢物。L-Threonic acid magnesium 是一种镁补充剂,可提高脑内镁浓度,抑制 TNF-α/NF-κB 信号通路的激活。L-Threonic acid magnesium 可用于阿尔茨海默病的研究。L-Threonic acid magnesium 具有口服活性。
    L-Threonic acid magnesium
  • HY-P1439A
    RS 09 TFA Activator 99.87%
    RS 09 TFA 是一种 LPS (HY-D1056) 肽模拟物和 TLR4 激动剂。RS 09 TFA 能结合 TLR-4 并激活 NF-κB。RS 09 TFA 可在体内作为佐剂发挥作用,增强抗原特异性免疫反应。
    RS 09 TFA
  • HY-N0716A
    Berberine hemisulfate

    硫酸黄连素; 硫酸小檗碱

    Inhibitor 99.63%
    Berberine hemisulfate 是 Berberine (HY-N0716) 的半硫酸盐形式。Berberine hemisulfate 是可以从中草药黄连中分离出来的生物碱。Berberine hemisulfate 具有抗炎、抗菌、抗肿瘤、心血管保护和神经保护活性。
    Berberine hemisulfate
  • HY-N0738
    Stachydrine hydrochloride

    盐酸水苏碱

    Inhibitor ≥98.0%
    Stachydrine hydrochloride 是益母草的主要活性成分,可用于心血管疾病的研究。Stachydrine hydrochloride 可以抑制 NF-κB 信号通路。具有抗心肌肥大活性 。
    Stachydrine hydrochloride
  • HY-120371
    CPUY192018 Inhibitor 98.90%
    CPUY192018 是一种有效的 Keap1-Nrf2 蛋白-蛋白相互作用抑制剂,IC50 为 0.63 µM。 CPUY192018 具有抗炎和抗氧化的活性。CPUY192018 能激活 Nrf2 依赖的抗氧化通路、抑制 NF-κB 相关炎症反应。CPUY192018 可用于炎症相关疾病的研究。
    CPUY192018
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.